Given that our blood is inside of our bodies, the only way to extract it would be to draw it out, such as with a needle. Not surprisingly there are many who aren’t particularly comfortable having their blood drawn, but some need to do that on a daily basis for health check, such as for diabetes.
This is why it is not surprising that companies such as Apple have been working on noninvasive methods of blood collection. As it turns out Apple is not alone because according to a report from CNBC (via 9to5Google), Alphabet’s Verily is also said to be working on similar technology which could be implemented into future wearables, such as smartwatches.
This is actually not the first time that the company has expressed interest in noninvasive medical technology. Like we said, blood collection is used to help monitor the glucose levels of diabetes patients, but several years ago Google (before Alphabet was formed) was already exploring similar technological concepts, such as a contact lens that can also be used to monitor glucose levels.
However whether or not Verily’s ambitions will come to fruition remains to be seen, but CNBC’s report suggests that the launch of such a device could be years away where the company will no doubt be faced with all kinds of hurdles. This is also a similar outlook on Apple’s alleged noninvasive glucose monitoring system which is also said to be years away from being a reality.